These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 21620441

  • 1. Glomerular filtration rate in patients with atrial fibrillation on warfarin treatment: a subgroup analysis from the AURICULA registry in Sweden.
    Jönsson KM, Wieloch M, Sterner G, Nyman U, Elmståhl S, Engström G, Svensson PJ.
    Thromb Res; 2011 Oct; 128(4):341-5. PubMed ID: 21620441
    [Abstract] [Full Text] [Related]

  • 2. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
    Poli D, Antonucci E, Zanazzi M, Grifoni E, Testa S, Ageno W, Palareti G.
    Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S, Bennett D, Smith DJ.
    Am J Cardiovasc Drugs; 2010 Jun; 10(1):37-48. PubMed ID: 20104933
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL, Polkinghorne KR, Atkins RC, Chadban SJ.
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease.
    Quinn MP, Rainey A, Cairns KJ, Marshall AH, Savage G, Kee F, Peter Maxwell A, Reaney E, Fogarty DG.
    Nephrol Dial Transplant; 2008 Feb; 23(2):542-8. PubMed ID: 17890743
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lower-dose warfarin delays renal progression and prolongs patient survival in patients with stage 3 - 5 chronic kidney disease and nonvalvular atrial fibrillation: a 12-year follow-up study.
    Chiu PF, Huang CH, Liou HH, Wu CL, Chang C, Chang CC, Chang HR.
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):504-8. PubMed ID: 24755133
    [Abstract] [Full Text] [Related]

  • 12. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
    Szummer K, Gasparini A, Eliasson S, Ärnlöv J, Qureshi AR, Bárány P, Evans M, Friberg L, Carrero JJ.
    J Am Heart Assoc; 2017 Mar 01; 6(3):. PubMed ID: 28249846
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults.
    Viktorsdottir O, Palsson R, Andresdottir MB, Aspelund T, Gudnason V, Indridason OS.
    Nephrol Dial Transplant; 2005 Sep 01; 20(9):1799-807. PubMed ID: 15928100
    [Abstract] [Full Text] [Related]

  • 14. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun 01; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The prevalence of atrial fibrillation in a geographically well-defined population in northern Sweden: implications for anticoagulation prophylaxis.
    Andersson P, Löndahl M, Abdon NJ, Terent A.
    J Intern Med; 2012 Aug 01; 272(2):170-6. PubMed ID: 22250988
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
    Roldán V, Marín F, Fernández H, Manzano-Fernández S, Gallego P, Valdés M, Vicente V, Lip GY.
    Am J Cardiol; 2013 Apr 15; 111(8):1159-64. PubMed ID: 23337836
    [Abstract] [Full Text] [Related]

  • 19. Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records.
    Nilsson GH, Björholt I.
    BMC Clin Pharmacol; 2004 Feb 09; 4():1. PubMed ID: 15028124
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care--an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates.
    Risch L, Saely CH, Neyer U, Hoefle G, Gouya G, Zerlauth M, Risch GM, Risch M, Drexel H.
    Clin Chim Acta; 2007 Mar 09; 378(1-2):71-7. PubMed ID: 17157286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.